Neutrophil gelatinase-associated lipocalin (NGAL) circulating levels are related to LDL Myocardial infarction

Abstract

Background: Low-density lipoprotein receptors (LDL-R) in hepatocytes are degraded by the enzyme Neiutrophophil gielatinase-associated lipocalin (NGAL) A brand-new target for lipid-lowering treatment is Neiutrophophil gielatinase-associated lipocalin (NGAL) inhibition. Three subsets of monocytes, which play a critical role in the pathophysiology of atherosclerosis, are known. Objectives: The aim of this study was to examine whether circulating levels of Neiutrophophil gielatinase-associated lipocalin (NGAL) are associated with LDL liped subsets. Materials and Methods: We included 70 patients with coronary artery disease. Neiutrophophil gielatinase-associated lipocalin (NGAL) levels were measured and LDL liped and 30 control health. Results: Eighty percent of the patients were men, with a mean age between 40 and 70. Patients increese displayed greater Neiutrophophil gielatinase-associated lipocalin (NGAL) -levels compared to the 30 male control group. Neiutrophophil gielatinase-associated lipocalin (NGAL) levels in the blood were associated with CM treatment in patients, whereas NCM had the opposite effect. Patients whose levels of Neiutrophophil gielatinase-associated lipocalin (NGAL) were greater than the median displayed a significantly higher. Conclusions: Endurance training, resistance training, and combined training improve cardiovascular risk factors associated with obesity. These types of training methods also improve cardiovascular risk factors in school obese children. Also, they can be used as effective exercise programs for these people. Therefore, EET, RET, and CET used in this study, especially EET, can be recommended as a non-medical way to improve the incidence of cardiovascular risk factors and obesity-related disorders in obese boys.